Residual C-peptide secretion is associated with better CGM-metrics in adults with short-lasting type 1 diabetes
C-peptide microsecretion is associated with a low risk of hypoglycemia and improved CGM metrics. Therapeutic approaches aimed at preserving minimal C-peptide secretion could potentially enhance glycemic outcomes and reduce hypoglycemic risk in individual with T1D.
Authors
- Raffaella Buzzetti (ORCID: https://orcid.org/0000-0003-1490-6041)
- Antonio De Siena
- Fabrizio Barbaro
- Renata Risi (ORCID: https://orcid.org/0000-0003-2905-4398)
- Simona Zampetti
- Luca D’Onofrio (ORCID: https://orcid.org/0000-0003-3905-0139)
- Francesco De Vita (ORCID: https://orcid.org/0000-0001-8616-269X)
- Ernesto Maddaloni (ORCID: https://orcid.org/0000-0003-3844-9463)
- Rosario Luigi Sessa (ORCID: https://orcid.org/0000-0002-4249-9802)
- Rocco Amendolara
- Dario Notarnicola
- Daniela Luverà
Institutions
- Sapienza University of Rome (IT)
Publication Details
- Journal
- Diabetes Research and Clinical Practice
- Published
- 2025-01-23
- DOI
- https://doi.org/10.1016/j.diabres.2025.112006
- Citations
- 6
- Primary Topic
- Diabetes and associated disorders
- Type
- article
- Field-Weighted Citation Impact
- 10.90
Funders
- Ministero dell’Istruzione, dell’Università e della Ricerca
- Sapienza Università di Roma